[Piracetam (Nootropil--ucb 6215), clinical trial].
D000081:Acetamides / Q000627:therapeutic use* / Q000633:toxicity; D000293:Adolescent; D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000188:drug therapy; D001247:Asthenia / Q000188:drug therapy; D003072:Cognition Disorders / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D011760:Pyrrolidinones / Q000627:therapeutic use* / Q000633:toxicity; D019966:Substance-Related Disorders / Q000188:drug therapy
D000081:Acetamides; D011760:Pyrrolidinones
Utilisation clinique du Piracétam (Nootropil--ucb 6215)